ACE and Alzheimer disease: Genetically predicted SBP was not associated with AD risk (OR 1.01, 95% CI 1.00–1.01 per mm Hg increase in SBP) using a genome-wide instrument, suggesting that although SBP colocalizes with cortical ACE expression at the ACE gene, reduction in SBP more generally is not directly associated with AD risk.